type-1-diabetes

Documents about type-1-diabetes

• A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes#827057ClinicalTrials.gov
• Impact of Dietary Knowledge Related to Functional Insulin Therapy in Type 1 Diabetes on the Risk of Eating Disorders#812358ClinicalTrials.gov
• Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel#195474ClinicalTrials.gov
• Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System#307408ClinicalTrials.gov
• Efficacy and Safety of Levemir® Used as Basal Insulin#405286ClinicalTrials.gov
• Evaluation of the GlucoTrack, Non-Invasive Glucose Monitoring Device#481724ClinicalTrials.gov
• Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)#803630ClinicalTrials.gov
• Mobile Communication Technology for Adolescents With Diabetes#407830ClinicalTrials.gov
• Can Glucose Monitoring Improve (CGMi Study)#429688ClinicalTrials.gov
• A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes#28496ClinicalTrials.gov
• Automated Closed-loop in Children and Adolescents With Type 1 Diabetes#184752ClinicalTrials.gov
• Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)#245426ClinicalTrials.gov
• Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)#805641ClinicalTrials.gov
• Turkish Version of The Diabetes Quality of Life Brief Clinical Inventory Validity and Reliability#217189ClinicalTrials.gov
• Assessing Remote Confirmation of Type 1 Diabetes#825096ClinicalTrials.gov
• Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes#123638ClinicalTrials.gov
• The Influence of Psychobiological Adversity to Children and Adolescents With Type 1 Diabetes#126031ClinicalTrials.gov
• A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes Mellitus#136274ClinicalTrials.gov
• A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus#152590ClinicalTrials.gov
• Pilot Study to Determine Effects of Salsalate in Type 1 Diabetes and Painful Peripheral Neuropathy#175023ClinicalTrials.gov
• Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes Mellitus#175052ClinicalTrials.gov
• Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes#181691ClinicalTrials.gov
• Updating Preventive and Treatment Guidelines for Hypoglycemia in Individuals Living With Type 1 Diabetes#181693ClinicalTrials.gov
• Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 Diabetes#184749ClinicalTrials.gov
• 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes#217178ClinicalTrials.gov
• Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes#230353ClinicalTrials.gov
• Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions (AP@Home04_Phase 4)#272262ClinicalTrials.gov
• The Integration of Physical Activity Into the Clinical Decision Process of People with Type 1 Diabetes#307385ClinicalTrials.gov
• Identifying Driving Risk Factors in Type 1 Diabetes and Their Reduction Via Internet Program (DiabetesDriving.Com)#343774ClinicalTrials.gov
• Use of Continuous Glucose Monitoring System With Intensive Feedback in Adolescents With Poorly Controlled Type 1 Diabetes#363573ClinicalTrials.gov
• The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus#369971ClinicalTrials.gov
• Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes#394705ClinicalTrials.gov
• A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes#407837ClinicalTrials.gov
• A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes#417514ClinicalTrials.gov
• Test of the Efficacy and Safety of Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes Mellitus#451415ClinicalTrials.gov
• Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany#451433ClinicalTrials.gov
• Biomarkers in Exhaled Breath of Glucose Fluctuation in Type 1 Diabetes#674840ClinicalTrials.gov
• European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice.#300378ClinicalTrials.gov
• A Study of LY8888AX in Participants Using a Connected Insulin Management Platform#414425ClinicalTrials.gov
• Comparison of Noninvasive Blood Glucose Concentrations Relative to Finger Capillary Blood Glucose References#141208ClinicalTrials.gov
• Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Systems#234569ClinicalTrials.gov
• Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction#314280ClinicalTrials.gov
• Physical Activity During Pregnancy in Women With Pre-existing Diabetes#802155ClinicalTrials.gov
• Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes#18816ClinicalTrials.gov
• Impact of Two Medtronic Infusion Sets on Lipohypertrophy in Type 1 Diabetes (T1DM) Patients Thought to Have LH#253158ClinicalTrials.gov
• Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes#683014ClinicalTrials.gov
• SweMaMi DMI, Microbiome#414400ClinicalTrials.gov
• Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients#18809ClinicalTrials.gov
• The Safety and Efficacy of Administrating DiaPep277® Vaccination in Type 1 Diabetes Patients.#454141ClinicalTrials.gov
• Glucotoxicity and Acute Exercise#804446ClinicalTrials.gov